Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

19.65
BATS BZX Real-Time Price
As of 10:03am ET
 +0.12 / +0.61%
Today’s Change
12.25
Today|||52-Week Range
27.02
+8.38%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close19.53
Today’s open19.99
Day’s range19.28 - 20.10
Volume31,573
Average volume (3 months)1,589,444
Market cap$1.2B
Dividend yield--
Data as of 10:03am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+51.47%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...-0.72-0.92%
ALDRAlder Biopharmaceuti...-0.30-1.28%
XNCRXencor Inc-0.04-0.15%
PCRXPacira Pharmaceutica...-0.35-1.13%
Data as of 10:01am ET, 12/06/2016

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts


Search for Jobs